A
Asif Johar
Researcher at Karolinska University Hospital
Publications - 79
Citations - 1524
Asif Johar is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 17, co-authored 59 publications receiving 1048 citations. Previous affiliations of Asif Johar include King's College London & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
TL;DR: Sarcopenia and sarcopenic obese OC patients may be at a higher risk for developing DLT during chemotherapy compared to non-sarcopenic OC patients, and logistic regression with BMI as an interaction term indicated higher risk.
Journal ArticleDOI
Hospital and Surgeon Volume in Relation to Survival After Esophageal Cancer Surgery in a Population-Based Study
TL;DR: Because surgeon volume rather than hospital volume independently influences the prognosis after esophageal cancer surgery, centralization of this surgery to fewer surgeons seems warranted.
Journal ArticleDOI
Low Anterior Resection Syndrome and Quality of Life After Sphincter-Sparing Rectal Cancer Surgery: A Long-term Longitudinal Follow-up.
Emil H A Pieniowski,G. Palmer,Therese Juul,Pernilla Lagergren,Asif Johar,Katrine J Emmertsen,Caroline Nordenvall,Mirna Abraham-Nordling +7 more
TL;DR: In this article, the authors investigated the long-term effect of low anterior resection syndrome on bowel function and quality of life after rectal cancer surgery and found that symptoms of LOS syndrome are associated with sphincter-preserving colon cancer.
Journal ArticleDOI
Extent of Lymph Node Removal During Esophageal Cancer Surgery and Survival
TL;DR: It is indicated that more extensive lymph node clearance during surgery for esophageal cancer may not improve survival, which challenge current clinical guidelines, and further research is needed to change clinical practice.
Journal ArticleDOI
Health-related quality of life 10 years after oesophageal cancer surgery
TL;DR: Patients who have undergone curative treatment for oesophageal cancer experience reduced HRQOL with persisting symptoms 10 years after surgery, with significant deterioration in global quality of life, role functioning, social functioning and most symptoms.